What is Nayzilam and How Does It Work?
Nayzilam is a nasal spray formulation of midazolam hydrochloride, used for the acute treatment of intermittent, stereotypic episodes of frequent motor activity associated with certain seizure disorders in adults and children 12 years of age and older [1]. It is a benzodiazepine that works by enhancing the effect of a neurotransmitter called GABA, which can calm brain activity and stop seizures [1].
How Much Does Nayzilam Cost Without Insurance?
The cost of Nayzilam without insurance can vary significantly. A single unit of Nayzilam nasal spray, which contains three 5 mg devices, can range from approximately $1,300 to over $2,500 [2]. This price reflects the manufacturer's list price, and actual out-of-pocket costs may differ based on pharmacy, location, and any available patient assistance programs.
Can I Get Financial Assistance for Nayzilam?
For individuals without insurance or those facing high out-of-pocket expenses, financial assistance programs may be available. The manufacturer of Nayzilam, UCB, offers programs such as UCB Well, which can provide support for eligible patients, potentially reducing the cost of medication [3]. Information on these programs can typically be found on the manufacturer's website or by speaking with a healthcare provider or pharmacist.
What is the Difference Between Nayzilam and Other Seizure Medications?
Nayzilam is specifically indicated for the acute, rescue treatment of seizures, meaning it is used to stop seizures when they occur, rather than for daily management of seizure frequency. Other seizure medications, such as levetiracetam (Keppra) or valproic acid, are typically taken daily to prevent seizures [1]. Nayzilam's nasal delivery offers a rapid route of administration, which can be advantageous in emergency situations [1].
When Do Nayzilam Patents Expire?
Patent information for medications like Nayzilam is crucial for understanding potential generic competition and future cost implications. DrugPatentWatch.com tracks patent expiry dates for various pharmaceuticals [4]. While specific patent expiry dates for Nayzilam would require consulting detailed patent databases, the exclusivity periods for branded drugs are generally designed to allow manufacturers to recoup research and development costs before generic alternatives can enter the market [4].